vs

Side-by-side financial comparison of FIRST US BANCSHARES, INC. (FUSB) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

FIRST US BANCSHARES, INC. is the larger business by last-quarter revenue ($10.4M vs $8.7M, roughly 1.2× Wave Life Sciences Ltd.). FIRST US BANCSHARES, INC. runs the higher net margin — 20.4% vs -580.2%, a 600.6% gap on every dollar of revenue. On growth, FIRST US BANCSHARES, INC. posted the faster year-over-year revenue change (7.1% vs -55.8%). FIRST US BANCSHARES, INC. produced more free cash flow last quarter ($9.1M vs $-46.3M). Over the past eight quarters, FIRST US BANCSHARES, INC.'s revenue compounded faster (2.6% CAGR vs -18.0%).

First Citizens Bancshares, Inc. is a bank holding company based in Raleigh, North Carolina and one of the largest banks in the United States. Its primary subsidiary is First Citizens Bank, which operates over 500 branches in 23 states. A second subsidiary is Silicon Valley Bank, which operates 39 offices in 15 states.

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

FUSB vs WVE — Head-to-Head

Bigger by revenue
FUSB
FUSB
1.2× larger
FUSB
$10.4M
$8.7M
WVE
Growing faster (revenue YoY)
FUSB
FUSB
+62.9% gap
FUSB
7.1%
-55.8%
WVE
Higher net margin
FUSB
FUSB
600.6% more per $
FUSB
20.4%
-580.2%
WVE
More free cash flow
FUSB
FUSB
$55.4M more FCF
FUSB
$9.1M
$-46.3M
WVE
Faster 2-yr revenue CAGR
FUSB
FUSB
Annualised
FUSB
2.6%
-18.0%
WVE

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
FUSB
FUSB
WVE
WVE
Revenue
$10.4M
$8.7M
Net Profit
$2.1M
$-50.5M
Gross Margin
Operating Margin
28.1%
-606.5%
Net Margin
20.4%
-580.2%
Revenue YoY
7.1%
-55.8%
Net Profit YoY
24.2%
-53.3%
EPS (diluted)
$0.36
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FUSB
FUSB
WVE
WVE
Q4 25
$10.4M
Q3 25
$10.5M
Q2 25
$10.3M
$8.7M
Q1 25
$9.8M
$9.2M
Q4 24
$9.7M
Q3 24
$10.1M
Q2 24
$10.0M
$19.7M
Q1 24
$9.9M
$12.5M
Net Profit
FUSB
FUSB
WVE
WVE
Q4 25
$2.1M
Q3 25
$1.9M
Q2 25
$155.0K
$-50.5M
Q1 25
$1.8M
$-46.9M
Q4 24
$1.7M
Q3 24
$2.2M
Q2 24
$2.1M
$-32.9M
Q1 24
$2.1M
$-31.6M
Operating Margin
FUSB
FUSB
WVE
WVE
Q4 25
28.1%
Q3 25
23.9%
Q2 25
1.6%
-606.5%
Q1 25
23.8%
-542.8%
Q4 24
23.8%
Q3 24
29.2%
Q2 24
27.4%
-177.7%
Q1 24
27.8%
-274.8%
Net Margin
FUSB
FUSB
WVE
WVE
Q4 25
20.4%
Q3 25
18.4%
Q2 25
1.5%
-580.2%
Q1 25
18.1%
-510.9%
Q4 24
17.6%
Q3 24
22.0%
Q2 24
21.2%
-167.2%
Q1 24
21.3%
-251.7%
EPS (diluted)
FUSB
FUSB
WVE
WVE
Q4 25
$0.36
Q3 25
$0.32
Q2 25
$0.03
$-0.31
Q1 25
$0.29
$-0.29
Q4 24
$0.29
Q3 24
$0.36
Q2 24
$0.34
$-0.25
Q1 24
$0.34
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FUSB
FUSB
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$73.5M
$208.5M
Total DebtLower is stronger
$10.9M
Stockholders' EquityBook value
$105.6M
$139.3M
Total Assets
$1.2B
$252.4M
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FUSB
FUSB
WVE
WVE
Q4 25
$73.5M
Q3 25
$54.7M
Q2 25
$54.0M
$208.5M
Q1 25
$56.0M
$243.1M
Q4 24
$47.2M
Q3 24
$82.3M
Q2 24
$58.2M
$154.0M
Q1 24
$60.2M
$180.9M
Total Debt
FUSB
FUSB
WVE
WVE
Q4 25
$10.9M
Q3 25
$10.9M
Q2 25
$10.9M
Q1 25
$10.9M
Q4 24
$10.9M
Q3 24
$10.9M
Q2 24
$10.8M
Q1 24
$10.8M
Stockholders' Equity
FUSB
FUSB
WVE
WVE
Q4 25
$105.6M
Q3 25
$104.2M
Q2 25
$101.9M
$139.3M
Q1 25
$101.2M
$171.8M
Q4 24
$98.6M
Q3 24
$98.5M
Q2 24
$93.8M
$-3.5M
Q1 24
$92.3M
$25.4M
Total Assets
FUSB
FUSB
WVE
WVE
Q4 25
$1.2B
Q3 25
$1.1B
Q2 25
$1.1B
$252.4M
Q1 25
$1.1B
$288.3M
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
$208.8M
Q1 24
$1.1B
$235.3M
Debt / Equity
FUSB
FUSB
WVE
WVE
Q4 25
0.10×
Q3 25
0.10×
Q2 25
0.11×
Q1 25
0.11×
Q4 24
0.11×
Q3 24
0.11×
Q2 24
0.12×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FUSB
FUSB
WVE
WVE
Operating Cash FlowLast quarter
$12.3M
$-46.0M
Free Cash FlowOCF − Capex
$9.1M
$-46.3M
FCF MarginFCF / Revenue
87.2%
-532.5%
Capex IntensityCapex / Revenue
31.1%
3.5%
Cash ConversionOCF / Net Profit
5.79×
TTM Free Cash FlowTrailing 4 quarters
$16.0M
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FUSB
FUSB
WVE
WVE
Q4 25
$12.3M
Q3 25
$4.2M
Q2 25
$3.9M
$-46.0M
Q1 25
$1.8M
$-63.0M
Q4 24
$7.8M
Q3 24
$1.9M
Q2 24
$2.5M
$-27.5M
Q1 24
$825.0K
$-33.4M
Free Cash Flow
FUSB
FUSB
WVE
WVE
Q4 25
$9.1M
Q3 25
$3.6M
Q2 25
$1.6M
$-46.3M
Q1 25
$1.7M
$-63.2M
Q4 24
$5.7M
Q3 24
$1.3M
Q2 24
$2.3M
$-27.5M
Q1 24
$-142.0K
$-33.8M
FCF Margin
FUSB
FUSB
WVE
WVE
Q4 25
87.2%
Q3 25
34.2%
Q2 25
16.0%
-532.5%
Q1 25
17.2%
-688.9%
Q4 24
58.2%
Q3 24
12.7%
Q2 24
23.5%
-139.8%
Q1 24
-1.4%
-270.0%
Capex Intensity
FUSB
FUSB
WVE
WVE
Q4 25
31.1%
Q3 25
5.9%
Q2 25
21.8%
3.5%
Q1 25
0.7%
1.8%
Q4 24
21.6%
Q3 24
6.6%
Q2 24
2.0%
0.3%
Q1 24
9.8%
3.3%
Cash Conversion
FUSB
FUSB
WVE
WVE
Q4 25
5.79×
Q3 25
2.18×
Q2 25
25.16×
Q1 25
0.99×
Q4 24
4.53×
Q3 24
0.87×
Q2 24
1.20×
Q1 24
0.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons